Peripheral Arterial Disease Clinical Trial
Official title:
Assessment of the Level of Precariousness in a Population of Patients With Symptomatic Peripheral Arterial Disease.
Atherosclerosis is a systemic disease that affects coronary, cerebral, and lower-extremity
arteries. Peripheral artery disease (PAD) is the manifestation of atherosclerosis in the
legs. Three different stages can be found: asymptomatic stage (stage 1), exercise ischemia
stage (stage 2) and rest ischemia stage (stage 3). The risk factors for PAD are similar to
those for coronary artery disease (CAD) and cerebrovascular disease (CBVD), like high blood
pressure, diabetes, smoking, dyslipidemia and obesity. But cigarette smoking is the single
most important risk factor for the development and progression of PAD.
PAD is a serious illness and an important predictor of cardiovascular disease with major
medico-economic consequences.
A low socioeconomic status (SES) is associated with higher cardiovascular mortality and
morbidity. In these vulnerable populations, there is an increase in the prevalence of
cardiovascular risk factors, particularly for smoking.
The main objective of this study was to assess the level of precariousness in patients with
symptomatic PAD and compare it to the level of precariousness in the general population.
Patients were recruited from vascular medicine and surgery department of Grenoble university
hospital or therapeutic education outpatient consultation.
The analysis of socio-economic and environmental data resulted in:
- EPICES score: (Evaluation of the Deprivation and Inequalities of Health in Healthcare
Centers score). The EPICES score is a quick and validated questionnaire to assess
precariousness at the individual level, developed by considering all the material and
psychosocial dimensions of precariousness.
Precariousness, according to the EPICES score, in the general population is estimated at 40%.
- INSEE parameters. The investigators completed the EPICES score with more traditional
indicators derived from The National Institute of Statistics and Economic Studies (INSEE)
collects, analyses and disseminates information on the French economy and society. The
investigators collected the level of education and professional practice based on the
nomenclature of socio-professional categories defined by INSEE.
Cardiovascular risk factors were also collected to measure the links between the level of
precariousness and cardiovascular risk factors.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06032065 -
Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD)
|
Phase 3 | |
| Active, not recruiting |
NCT03987061 -
MOTIV Bioresorbable Scaffold in BTK Artery Disease
|
N/A | |
| Recruiting |
NCT03506633 -
Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease Patients
|
N/A | |
| Active, not recruiting |
NCT03506646 -
Dietary Nitrate Supplementation and Thermoregulation
|
N/A | |
| Active, not recruiting |
NCT04677725 -
NEtwork to Control ATherothrombosis (NEAT Registry)
|
||
| Recruiting |
NCT05961943 -
RESPONSE-2-PAD to Reduce Sedentary Time in Peripheral Arterial Disease Patients
|
N/A | |
| Recruiting |
NCT06047002 -
Personalised Antiplatelet Therapy for Patients With Symptomatic Peripheral Arterial Disease
|
||
| Completed |
NCT03185052 -
Feasibility of Outpatient Care After Manual Compression in Patients Treated for Peripheral Arterial Disease by Endovascular Technique With 5F Sheath Femoral Approach
|
N/A | |
| Recruiting |
NCT05992896 -
A Study of Loco-Regional Liposomal Bupivacaine Injection
|
Phase 4 | |
| Completed |
NCT04635501 -
AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial
|
N/A | |
| Recruiting |
NCT04584632 -
The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery
|
N/A | |
| Withdrawn |
NCT03994185 -
The Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease
|
N/A | |
| Withdrawn |
NCT03538392 -
Serranator® Alto Post Market Clinical Follow Up (PMCF) Study
|
||
| Recruiting |
NCT02915796 -
Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty
|
Phase 1 | |
| Active, not recruiting |
NCT02900924 -
Observational Study to Evaluate the BioMimics 3D Stent System: MIMICS-3D
|
||
| Completed |
NCT02901847 -
To Evaluate the Introduction of a Public Health Approach to Peripheral Arterial Disease (PAD) Using National Centre for Sport and Exercise Medicine Facilities.
|
N/A | |
| Not yet recruiting |
NCT02387450 -
Reduced Cardiovascular Morbi-mortality by Sildenafil in Patients With Arterial Claudication
|
Phase 2/Phase 3 | |
| Withdrawn |
NCT02126540 -
Trial of Pantheris System, an Atherectomy Device That Provides Imaging While Removing Plaque in Lower Extremity Arteries
|
N/A | |
| Not yet recruiting |
NCT02455726 -
Magnesium Oral Supplementation to Reduce Pain Inpatients With Severe Peripheral Arterial Occlusive Disease
|
N/A | |
| Completed |
NCT02022423 -
Physical Activity Daily - An Internet-Based Walking Program for Patients With Peripheral Arterial Disease
|
N/A |